Nvidia Corp vs Revvity Inc — how do they compare? Nvidia Corp trades at $206.35 (market cap $4.92T), while Revvity Inc trades at $110.1 (market cap $11.87B). The key difference: Nvidia Corp is far larger — about 414.5× Revvity Inc's market cap, and Nvidia Corp pays the higher dividend (0.49%). Which is the better fit depends on your goals.
| NVDA | RVTY | |
|---|---|---|
Market Cap | $4.92T | $11.87B |
Sector | Technology | Technology |
52-Week High | $235.75 | $117.75 |
52-Week Low | $165.17 | $82.26 |
Enterprise Value | $4.86T | $14.36B |
Dividend Yield | 0.49% | 0.26% |
Signals from Pluang's Aura AI — not financial advice
NVIDIA (NVDA) trades at $207.14, up 2.14% today, with a neutral technical signal and strong fundamentals. Recent earnings beats and robust profitability margins highlight operational strength. The stock is supported by a consensus analyst price target of $325.86, though it faces technical resistance near $210.
Outlook remains positive driven by AI chip demand, but risks include competition and market volatility. Revenue growth acceleration and high institutional ownership suggest long-term potential, yet valuation multiples require sustained execution to justify further upside.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
NVIDIA Corporation designs, develops, and markets three dimensional (3D) graphics processors and related software. The Company offers products that provides interactive 3D graphics to the mainstream personal computer market.
Read more on NVDA →Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →